Pall Introduces 13 mm Acrodisc® MS Syringe Filter Certified for Low LCMS Extractables in Small Samples

Thu Feb 28, 2013 6:30am EST

* Reuters is not responsible for the content in this press release.

PORT WASHINGTON, N.Y.--(Business Wire)--
Pall Corporation (NYSE:PLL) has introduced a 13 mm Acrodisc® MS syringe filter
certified for low extractables in high performance liquid chromatography/mass
spectrometry (LCMS) applications. The new 13 mm size, which is designed
specifically for small sample analysis using LCMS, complements Pall`s current
Acrodisc MS syringe filter offering of a 25 mm filter. The 13 mm Acrodisc MS
syringe filter improves the accuracy of testing, enhances LCMS performance, and
extends the longevity of testing instrumentation.
Pall's new 13 mm Acrodisc MS syringe filter (Photo: Business Wire)

The low extractable levels of the new 13 mm Acrodisc MS syringe filter minimize
interference with the ionization process and reduce the need for retesting. This
lowers costs while minimizing downtime due to unexpected contamination. To
ensure high performance, product tubes are packaged individually so that filters
not in use remain sealed and protected from external contamination. 

Constructed with Pall`s new water wettable polytetrafluoroethylene (WWPTFE)
membrane in a unique high density polyethylene housing, the Acrodisc MS syringe
filter can be used with both organic and aqueous solvents. It offers excellent
chemical resistance and good particulate retention with minimal protein
adsorption. This protects instrument columns from particulate build-up and
reduces the frequency and cost of replacement. It also enables more consistent
LCMS testing performance. 

"Pall`s 13 mm Acrodisc MS syringe filter is the newest innovation in our
comprehensive line of syringe filters and is suitable for samples as small as 25
µL," said Larry O`Connell, senior vice president, Pall Laboratory Products. "Our
new size will continue to improve the accuracy, cost, and reliability of high
performance LCMS testing. The applications for this advancement are extensive
and growing rapidly as testing technology advances." 

To learn more about the Acrodisc MS syringe filter and other Pall Life Sciences
laboratory products, visit 

Pall Life Sciences

Pall Life Sciences provides cutting-edge products and services to meet the
demanding needs of customers discovering, developing and producing biotech
drugs, vaccines and classic pharmaceuticals. The company`s membranes and
membrane devices optimize detection and sample preparation in the drug research,
clinical diagnostics, genomics, and proteomics markets. Pall is a leading
provider of separation systems and single-use filtration and purification
technologies to pharmaceutical and biotechnology companies to support faster
development of new drugs and vaccines that are safer and require less energy and
water to produce. Pall technologies are also used in clinical institutions and
the food and beverage industries. 

About Pall Corporation

Pall Corporation (NYSE:PLL) is a filtration, separation and purification leader
providing solutions to meet the critical fluid management needs of customers
across the broad spectrum of life sciences and industry. Pall works with
customers to advance health, safety and environmentally responsible
technologies. The company`s engineered products enable process and product
innovation and minimize emissions and waste. Pall Corporation is an S&P 500
company serving customers worldwide. Pall has been named a "top green company"
by Newsweek magazine. To see how Pall is helping enable a greener, safer, more
sustainable future, follow us on Twitter @PallCorporation or visit 

Note to Editors: A high-resolution photograph of the 13 mm Acrodisc MS syringe
filter is available for download at

Photos/Multimedia Gallery Available:

Pall Corporation
Laura Zaborski
Marketing Communications Manager
Telephone: 734-913-6488

Copyright Business Wire 2013